(Q27851805)

3

object named as

Zhen Shang

0 references

author name string

Kuang-Guo Zhou

1

0 references

Li-Jun Jiang

2

0 references

Jue Wang

4

0 references

Jian-Feng Zhou

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

6

0 references

publication date

December 2012

0 references

published in

Leukemia & Lymphoma

0 references

volume

53

0 references

page(s)

2423-9

0 references

issue

12

0 references

cites work

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

Bias in meta-analysis detected by a simple, graphical test

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

Operating characteristics of a rank correlation test for publication bias

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

DNMT3A Mutations in Acute Myeloid Leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor

21 April 2017

1 reference

https://api.crossref.org/works/10.3109/10428194.2012.695359

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

21 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

IDH2 mutations in patients with acute myeloid leukemia: missense p.R140 mutations are linked to disease status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

Therapy insight: Potential of statins for cancer chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.695359

10.3109/10428194.2012.695359

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3607306

3607306

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference